MedTrace Logo

Drug Use Surveillance of Vonoprazan for "Gastric Ulcer, Duodenal Ulcer, and Reflux Esophagitis"

NCT03214952 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3183

Last updated 2019-12-12

Study results available
· View outcomes & findings →

Summary

The purpose of this survey is to evaluate the safety and effectiveness of vonoprazan tablets in patients with gastric ulcer, duodenal ulcer, and reflux esophagitis in the routine clinical setting.

Conditions

  • Gastric Ulcer, Duodenal Ulcer, and Reflux Esophagitis

Interventions

DRUG

Vonoprazan

Vonoprazan tablets

Sponsors & Collaborators

Principal Investigators

  • Study Director · Takeda

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-03-01
Primary Completion
2018-10-31
Completion
2018-10-31

Countries

  • Japan

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03214952 on ClinicalTrials.gov